Suppr超能文献

血栓形成倾向筛查:并非如此简单。

Thrombophilia Screening: Not So Straightforward.

机构信息

Specialist Haemostasis Laboratory, Cambridge Haemophilia and Thrombophilia Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.

Department of Natural Sciences, Middlesex University, London, United Kingdom.

出版信息

Semin Thromb Hemost. 2024 Nov;50(8):1131-1152. doi: 10.1055/s-0044-1786807. Epub 2024 May 11.

Abstract

Although inherited thrombophilias are lifelong risk factors for a first thrombotic episode, progression to thrombosis is multifactorial and not all individuals with inherited thrombophilia develop thrombosis in their lifetimes. Consequently, indiscriminate screening in patients with idiopathic thrombosis is not recommended, since presence of a thrombophilia does not necessarily predict recurrence or influence management, and testing should be selective. It follows that a decision to undertake laboratory detection of thrombophilia should be aligned with a concerted effort to identify any significant abnormalities, because it will inform patient management. Deficiencies of antithrombin and protein C are rare and usually determined using phenotypic assays assessing biological activities, whereas protein S deficiency (also rare) is commonly detected with antigenic assays for the free form of protein S since available activity assays are considered to lack specificity. In each case, no single phenotypic assay is capable of detecting every deficiency, because the various mutations express different molecular characteristics, rendering thrombophilia screening repertoires employing one assay per potential deficiency, of limited effectiveness. Activated protein C resistance (APCR) is more common than discrete deficiencies of antithrombin, protein C, and protein S and also often detected initially with phenotypic assays; however, some centres perform only genetic analysis for factor V Leiden, as this is responsible for most cases of hereditary APCR, accepting that acquired APCR and rare mutations conferring APCR will go undetected if only factor V Leiden is evaluated. All phenotypic assays have interferences and limitations, which must be factored into decisions about if, and when, to test, and be given consideration in the laboratory during assay performance and interpretation. This review looks in detail at performance and limitations of routine phenotypic thrombophilia assays.

摘要

虽然遗传性血栓形成倾向是首次血栓形成事件的终身危险因素,但血栓形成的进展是多因素的,并非所有遗传性血栓形成倾向患者都会在其一生中发生血栓形成。因此,不建议对特发性血栓形成患者进行无差别筛查,因为血栓形成倾向并不能必然预测复发或影响管理,且检测应具有选择性。因此,进行血栓形成倾向实验室检测的决定应与识别任何显著异常的努力相一致,因为这将为患者管理提供信息。抗凝血酶和蛋白 C 的缺乏较为罕见,通常使用评估生物活性的表型检测进行确定,而蛋白 S 缺乏(也较为罕见)通常通过抗原检测法检测游离蛋白 S 的形式进行,因为可用的活性检测法被认为缺乏特异性。在每种情况下,单一表型检测都无法检测到所有的缺乏,因为各种突变表达不同的分子特征,使得使用一种检测法针对每种潜在缺乏的血栓形成倾向筛查方案的效果有限。活化蛋白 C 抵抗(APCR)比抗凝血酶、蛋白 C 和蛋白 S 的离散缺乏更为常见,最初也通常通过表型检测进行检测;然而,一些中心仅对因子 V Leiden 进行基因分析,因为这是遗传性 APCR 的主要原因,接受如果仅评估因子 V Leiden,将无法检测到获得性 APCR 和罕见的赋予 APCR 的突变。所有表型检测都存在干扰和限制,在决定是否进行检测以及何时进行检测时,必须将这些因素纳入考虑范围,并在实验室检测期间进行考虑。本综述详细探讨了常规表型血栓形成倾向检测的性能和限制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验